Business Description
Vectus Biosystems is an Australian medical research company focused on finding new ways to treat fibrosis, a condition where organs such as the heart, kidneys, lungs, and liver lose healthy tissue due to scarring. Its most advanced drug candidate, VB0004, is currently being tested in human clinical trials. The company also has plans to expand its research into liver and lung diseases linked to fibrosis.
